Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiamma Buttitta

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patientsFederico Cappuzzo, Antonio Marchetti, Margaret Skokan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancerFrancesca Molinari, Lara Felicioni, Michela Buscarino, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2013
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapyLucia Veronica Cuorvo, Paolo Verderio, Chiara Maura Ciniselli, et al.
JCO Precision Oncology|February 17, 2022
<i>ROS1</i> Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic AlgorithmAntonio Marchetti, Massimo Barberis, Alessia Di Lorito, et al.
Critical Reviews in Oncology/Hematology|October 10, 2020
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patientsUmberto Malapelle, Giulio Rossi, Pasquale Pisapia, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
The International Journal of Biological Markers|September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysisAngelo Paradiso, Anita Mangia, Claudio Orlando, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patientsFederico Cappuzzo, Antonio Marchetti, Margaret Skokan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancerFrancesca Molinari, Lara Felicioni, Michela Buscarino, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2013
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapyLucia Veronica Cuorvo, Paolo Verderio, Chiara Maura Ciniselli, et al.
JCO Precision Oncology|February 17, 2022
<i>ROS1</i> Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic AlgorithmAntonio Marchetti, Massimo Barberis, Alessia Di Lorito, et al.
Critical Reviews in Oncology/Hematology|October 10, 2020
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patientsUmberto Malapelle, Giulio Rossi, Pasquale Pisapia, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
The International Journal of Biological Markers|September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysisAngelo Paradiso, Anita Mangia, Claudio Orlando, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Pageof 6